Literature DB >> 15606801

Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.

Koenraad F Van Der Sluijs1, Leontine J R Van Elden, Ramon Arens, Monique Nijhuis, Rob Schuurman, Sandrine Florquin, Joan Kwakkel, Shizuo Akira, Henk M Jansen, René Lutter, Tom Van Der Polls.   

Abstract

T helper 1 driven immune responses facilitate host defence during viral infections. Because interleukin-18 (IL-18) mediates T helper 1 driven immune responses, and since mature IL-18 is up-regulated in human macrophages after influenza virus infection in vitro, it has been suggested that IL-18 plays an important role in the immune response to influenza. To determine the role of IL-18 in respiratory tract infection with influenza, IL-18 gene-deficient (IL-18(-/-)) and normal wildtype mice were intranasally inoculated with influenza A virus. Influenza resulted in an increase in constitutively expressed IL-18 in the lungs of wildtype mice. The clearance of influenza A was inhibited by IL-18, as indicated by reduced viral loads on day 8 and day 12 after infection in IL-18(-/-) mice. This enhanced viral clearance correlated with increased CD4(+) T-cell activation in the lungs as reflected by CD69 expression on the cell surface. Surprisingly, interferon-gamma (IFN-gamma) levels were similar in the lungs of IL-18(-/-) mice and wildtype mice. Intracellular IFN-gamma staining revealed similar expression levels in lung-derived natural killer cells, CD4(+) and CD8(+) T cells, indicating that IFN-gamma production is IL-18-independent during influenza virus infection. Tumour necrosis factor-alpha production by CD4(+) T cells was significantly lower in IL-18(-/-) mice than in wildtype mice. Our data indicate that endogenous IL-18 impairs viral clearance during influenza A infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15606801      PMCID: PMC1782065          DOI: 10.1111/j.1365-2567.2004.02000.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation.

Authors:  J Pirhonen; T Sareneva; I Julkunen; S Matikainen
Journal:  Eur J Immunol       Date:  2001-03       Impact factor: 5.532

2.  Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production.

Authors:  M J Micallef; T Ohtsuki; K Kohno; F Tanabe; S Ushio; M Namba; T Tanimoto; K Torigoe; M Fujii; M Ikeda; S Fukuda; M Kurimoto
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

3.  In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.

Authors:  M Tanaka-Kataoka; T Kunikata; S Takayama; K Iwaki; K Ohashi; M Ikeda; M Kurimoto
Journal:  Cytokine       Date:  1999-08       Impact factor: 3.861

4.  Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells.

Authors:  T Dao; K Ohashi; T Kayano; M Kurimoto; H Okamura
Journal:  Cell Immunol       Date:  1996-11-01       Impact factor: 4.868

5.  A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing.

Authors:  Alessia Gaggero; Alessandro De Ambrosis; Delia Mezzanzanica; Tiziana Piazza; Anna Rubartelli; Mariangela Figini; Silvana Canevari; Silvano Ferrini
Journal:  Oncogene       Date:  2004-09-30       Impact factor: 9.867

6.  Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression.

Authors:  Arthur Kaser; Susanne Kaser; Nicole C Kaneider; Barbara Enrich; Christian J Wiedermann; Herbert Tilg
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

7.  Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity.

Authors:  Beixing Liu; Isamu Mori; Md Jaber Hossain; Li Dong; Kiyoshi Takeda; Yoshinobu Kimura
Journal:  J Gen Virol       Date:  2004-02       Impact factor: 3.891

8.  Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice.

Authors:  A Hamilton-Easton; M Eichelberger
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

Review 9.  Interleukin-18 and host defense against infection.

Authors:  Charles A Dinarello; Giamila Fantuzzi
Journal:  J Infect Dis       Date:  2003-06-15       Impact factor: 5.226

10.  Recognition of single-stranded RNA viruses by Toll-like receptor 7.

Authors:  Jennifer M Lund; Lena Alexopoulou; Ayuko Sato; Margaret Karow; Niels C Adams; Nicholas W Gale; Akiko Iwasaki; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

View more
  18 in total

1.  Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury.

Authors:  Risa Nakamura; Naoyoshi Maeda; Kensuke Shibata; Hisakata Yamada; Tetsuo Kase; Yasunobu Yoshikai
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

2.  Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.

Authors:  Alexander B Mullen; Catherine E Lawrence; Emma McFarlane; Xiao-Quing Wei; Katharine C Carter
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

Review 3.  Caspase-1-induced pyroptotic cell death.

Authors:  Edward A Miao; Jayant V Rajan; Alan Aderem
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 4.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

Review 5.  New fronts emerge in the influenza cytokine storm.

Authors:  Xi-Zhi J Guo; Paul G Thomas
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

6.  Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study.

Authors:  Marcel Schouten; Koenraad F van der Sluijs; Bruce Gerlitz; Brian W Grinnell; Joris J T H Roelofs; Marcel M Levi; Cornelis van 't Veer; Tom van der Poll
Journal:  Crit Care       Date:  2010-04-14       Impact factor: 9.097

Review 7.  IL-1beta processing in host defense: beyond the inflammasomes.

Authors:  Mihai G Netea; Anna Simon; Frank van de Veerdonk; Bart-Jan Kullberg; Jos W M Van der Meer; Leo A B Joosten
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

8.  Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.

Authors:  Ping An; Chloe L Thio; Gregory D Kirk; Sharyne Donfield; James J Goedert; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

Review 9.  Natural killer cells in infection and inflammation of the lung.

Authors:  Fiona J Culley
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

10.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.

Authors:  Edward A Miao; Irina A Leaf; Piper M Treuting; Dat P Mao; Monica Dors; Anasuya Sarkar; Sarah E Warren; Mark D Wewers; Alan Aderem
Journal:  Nat Immunol       Date:  2010-11-07       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.